|
|
 |
|
Viewing report
|
|
|
|
Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for Biosimilars
GlobalData, Sep 2011, Pages: 13
Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for Biosimilars
Summary
GlobalData, the industry analysis specialist, has released its new report, “Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for Biosimilars”. The report is an essential source of information and analysis on the global biosimilar market opportunity. The report identifies the key trends shaping and driving the global biosimilars market. The report also provides insights on the major revenue generating product segments, regulatory environement and the key events expected to significantly alter the market positioning of the biopharmaceuticals. Most importantly, the report provides valuable insights on the industry trends expected to occur within the biosimilar space following the successful implementation of new legislations in the US. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the key drivers and challenges of the biosimilars market. Its scope includes -
- Annualized market opportunity for biosimilars industry, market revenues data from 2005 to 2010, forecast for eight years to 2020.
- Monitoring of biopharmacetical industry performance that covers high revenue generating product classes and top brands.
- Review on the regulatory landscape and legislation laws in the US and the Europe.
- Analysis on the biosimilar adoption and pricing in the five major European countries and the US.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include biopharmaceutical market performance, regulatory landscape, market opportunity for biosimilars and adoption of biosimilars.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of biosimilar products.
- Develop business strategies by understanding the trends shaping and driving the global biosimilar market.
- Formulate effective sales and marketing strategies by understanding the regulatory landscape and by analyzing the performance of various competitors.
|
|
|
|
